ESG

T1 Energy's upcoming results are the first major test of its pivot to U.S. solar manufacturing. Can it deliver on its high-stakes bet?

With regulatory approval for its CD&R acquisition, the maker of BUBBLE WRAP® is leaving the stock market. What does this mean for the industry?

A new AI system offers continuous, camera-free monitoring in patient rooms, aiming to prevent falls and assaults between scheduled staff check-ins.

UK biotech Amphista to showcase its innovative Targeted Glue™ platform at AACR, revealing new data for AML, lung cancer, and mesothelioma therapies.

A new partnership between Basys.ai and ePathUSA will use 'agentic AI' to overhaul medical record review, aiming to curb waste and improve efficiency.

Charité, Germany's leading hospital, adopts Coreline Soft's AI, signaling a major shift toward standardized, tech-driven national cancer detection.

An $80 million settlement aims to close the chapter on The Villages Health bankruptcy, a crisis sparked by hundreds of millions in Medicare billing errors.

Amidst financial pressures and a major restructuring, Verde Clean Fuels appoints its CFO as CEO to explore strategic options, including a potential sale.

Telehealth platforms like ReflexMD offer cheaper, compounded GLP-1s for weight loss. But what are the risks, and what do consumers need to know?

A massive investment in a key Montreal factory aims to modernize iconic brands, secure over 1,000 jobs, and strengthen Canada's domestic food supply chain.

A $135,000 grant aims to tackle severe health risks of social isolation through innovative, community-based programs at 21 senior centers across the state.

Texas LNG's decision to build key components in-state aims to sidestep global risks, create hundreds of local jobs, and redefine cleaner energy exports.

With 17 abstracts at AAD 2026, LEO Pharma showcases real-world data to tackle treatment gaps in diverse populations and chronic skin diseases.

Savaria’s consistent dividend signals robust financial health, tapping into a growing market driven by powerful demographic shifts and the 'aging in place' trend.

A new pilot in LA proves that smart design, not sacrifice, is the key to massive water savings and a better quality of life at home.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

A brain aneurysm device successful in Europe has treated its first U.S. patient in a pivotal trial, promising to expand treatment options for thousands.

IntraBio's landmark FDA submission for levacetylleucine offers the first glimmer of an approved therapy for the devastating rare disease Ataxia-Telangiectasia.

Spanish ceramic manufacturers are leading a design revolution, transforming tile from a simple surface into an architectural and sustainable centerpiece.

A 30-year-old breakthrough could revolutionize physics and cancer detection. Its inventor now demands a public test to prove it, alleging a cover-up.